Headquartered in Milford, Massachusetts, PLC Systems Inc. is a medical technology company specializing in innovative technologies for the cardiac and vascular markets.

PLC's newest product, RenalGuard^®, has been developed to help prevent the onset of contrast-induced nephropathy(CIN) in at-risk patients undergoing certain imaging procedures. It is already approved for sale in the EU for general fluid balancing. Two investigator-sponsored European studies have demonstrated RenalGuard's effectiveness at preventing CIN. RenalGuard is being studied in a pivotal trial in the U.S., as required for approval by the FDA.

The RenalGuard System™ consists of a closed loop, software-controlled console and single-use sets that physicians and nurses use for automated matched fluid replacement to minimize over- or under-hydration of patients during medical procedures where creating and maintaining high urine outputs is beneficial.

PLC Medical Systems, Inc.
459 Fortune Boulevard
Milford, MA 01757

Tel (508) 541-8800
Fax (508) 541-7980
Email info@plcmed.com

www.PLCMed.com